Name: Neuroprotection of Pioglitazone in Parkinson's Disease (en Inglés)
Price: 225134.00 COP
Availability: InStock
Author: Kohl Barbiero de Souza, Janaina
ISBN: 9786206464648

portada Neuroprotection of Pioglitazone in Parkinson's Disease (en Inglés)

Formato

Libro Físico

Autor

Janaina Kohl Barbiero de Souza

Editorial

Our Knowledge Publishing

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

Dimensiones

22.9 x 15.2 x 0.3 cm

Peso

0.09 kg.

ISBN13

9786206464648

Categorías

Farmacología

Neuroprotection of Pioglitazone in Parkinson's Disease (en Inglés)

Janaina Kohl Barbiero de Souza (Autor) · Our Knowledge Publishing · Tapa Blanda

Libro Nuevo

$ 225.134

$ 346.360

Ahorras: $ 121.226

35% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Miércoles 31 de Julio y el Viernes 09 de Agosto.

Lo recibirás en cualquier lugar de Colombia entre 1 y 5 días hábiles luego del envío.

Reseña del libro "Neuroprotection of Pioglitazone in Parkinson's Disease (en Inglés)"

Parkinson's disease, characterised by the degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNpc), is the second neurodegenerative disease after Alzheimer's, affecting approximately 1% of the population aged around 65. The disease is characterised clinically by resting tremor, rigidity, bradykinesia and postural instability. Pioglitazone, a peroxisome proliferator-activated receptor agonist, has been shown to attenuate dopaminergic cell loss in the MPTP animal model of PD, an effect attributed to its anti-inflammatory properties. The present study investigated the motor and cognitive effects obtained by pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, in an intranigral MPTP-induced Parkinson's disease model. Results showed that acute treatment generated some levels of neuroprotection. In contrast, chronic treatment led to a reduction in striatal DA caused by MPTP. These findings suggest that acute administration of pioglitazone 30mg/kg was more effective in generating beneficial effects on motor behaviour and striatal DA levels.